Skip to main content
OpenTrials
Completed

NCT Number: NCT01205789

EXCEL Clinical Trial (Universal Registry)

The purpose of the Universal Registry is to assess the proportion and reasons for which subjects with angiographically significant ULMCA disease requiring revascularization during the time course of this study are not randomized; to compare the baseline characteristics of subjects; and to assess the variability in randomization eligibility and treatment patterns.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Chronic Coronary Occlusion Arterial Occlusive Diseases Arteriosclerosis Cardiovascular Diseases Coronary Artery Disease Coronary Artery Stenosis Coronary Disease Coronary Restenosis Coronary Stenosis Heart Diseases Left Main Coronary Artery Disease Myocardial Ischemia Stent Thrombosis Vascular Disease Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Abbott Vascular

Santa Clara, California, 95054, United States

About this study

Approximately 100 consecutive subjects who otherwise meet all enrollment criteria, will be analyzed separately as intermediate lesion subjects, and will be followed through the time of initial treatment per standard of care with intended PCI, CABG or medical treatment.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Subjects who are either not eligible for randomization or for other reasons are not randomized will be consented for the Universal Registry

Treatment and study plan

Primary outcomes

  1. This study has no Primary outcome measure, it is an observational study to collect information on subjects not randomized to the RCT portion of the study.

    Time frame: At the time of enrollment into the study

    The purpose of the Universal Registry is to assess the proportion and reasons for which subjects with angiographically significant ULMCA disease requiring revascularization during the time course of this study are not randomized; to compare the baseline characteristics of subjects; and to assess the variability in randomization eligibility and treatment patterns.

    There are no follow-up time points for this study.

Sponsors and collaborators

Lead sponsor

Abbott Medical Devices

Industry

Registry information

Acronym: EXCEL

Important dates

Study start
2010
Primary completion
2012
Study completion
2012
First posted
Sep 20, 2010
Registry last updated
Dec 4, 2012

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.